跳至主要内容
临床试验/NCT01842711
NCT01842711已完成不适用

Exclusive Cumulative Irritation Patch Test (21 Day) With Challenge Patch Application

Chattem, Inc.1 个研究点 分布在 1 个国家目标入组 224 人开始时间: 2012年9月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
Chattem, Inc.
入组人数
224
试验地点
1
主要终点
Primary or Cumulative Irritation Potential of the skin

研究概览

简要总结

A Cumulative Patch Test with a Challenge Phase is a test devised to ascertain if a chemical agent or agents have the potential to cause contact irritation or contact allergy in the skin. Allergy is only elicited in immunologically competent individuals who have become sensitized through exposure to the chemical agent at a sufficient concentration and for a sufficient duration of time.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Cross Sectional

入排标准

年龄范围
16 Years 至 79 Years(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Subjects must not have any visible skin disease that might be confused with a skin reaction to the test trial;
  • Subjects must not be participating in another clinical trial at this facility or any other facility;
  • Subjects must be willing to avoid using topical or systemic steroids or antihistamines for at least 7 days prior to trial initiation and during the duration of the trial;
  • Subjects must understand and execute and Informed Consent Form;
  • Subjects must be capable of understanding and following directions;
  • Subjects must be considered reliable;
  • Subjects must be aged 16 to 79 years, inclusive;
  • Subjects aged less than 18 years must have a parent or legal guardian execute the Informed Consent Form.

排除标准

  • Subjects in ill health or taking medications, other than birth control, which could influence the purpose, integrity or outcome of the trial;
  • Female subjects who report orally they are pregnant, planning to become pregnant or nursing during the course of the trial;
  • Subjects who have a history of adverse reactions to adhesive tape, cosmetics, Over-The-Counter drugs or other personal care products;
  • Subjects judged by the PI to be inappropriate for the trial.

结局指标

主要结局

Primary or Cumulative Irritation Potential of the skin

时间窗: 21 days

This will be measured by the evaluation of the test sites (skin)by a trained assessor with a predetermined scale for skin irritation.

次要结局

  • Allergic Contact Sensitization Potential(21 days)

研究者

发起方
Chattem, Inc.
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验